New Age Care, LLC v. Caroline Juran, Executive Director

CourtCourt of Appeals of Virginia
DecidedJanuary 7, 2020
Docket1070192
StatusPublished

This text of New Age Care, LLC v. Caroline Juran, Executive Director (New Age Care, LLC v. Caroline Juran, Executive Director) is published on Counsel Stack Legal Research, covering Court of Appeals of Virginia primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
New Age Care, LLC v. Caroline Juran, Executive Director, (Va. Ct. App. 2020).

Opinion

COURT OF APPEALS OF VIRGINIA

Present: Judges O’Brien, Malveaux and Senior Judge Clements Argued at Richmond, Virginia PUBLISHED

NEW AGE CARE, LLC OPINION BY v. Record No. 1070-19-2 JUDGE MARY GRACE O’BRIEN JANUARY 7, 2020 CAROLINE JURAN, EXECUTIVE DIRECTOR, VIRGINIA BOARD OF PHARMACY AND DHARMA PHARMACEUTICALS, LLC

FROM THE CIRCUIT COURT OF HENRICO COUNTY L. A. Harris, Jr., Judge

Gregory J. DuBoff (Stanley A. Roberts; McGuire Woods LLP, on briefs), for appellant.

James E. Rutkowski, Assistant Attorney General (Mark R. Herring, Attorney General; Cynthia V. Bailey, Deputy Attorney General; Allyson K. Tysinger, Senior Assistant Attorney General, on brief), for appellee Caroline Juran, Executive Director, Virginia Board of Pharmacy.

J. Scott Sexton (Scott A. Stephenson; Gentry Locke, on brief), for appellee Dharma Pharmaceuticals, LLC.

This case involves an appeal pursuant to the Virginia Administrative Process Act (“the

VAPA”), Code §§ 2.2-4000 to -4031. New Age Care, LLC (“New Age”) and Dharma

Pharmaceuticals, LLC (“Dharma”) applied to the Virginia Board of Pharmacy (“the Board”) for a

pharmaceutical processor permit to operate a facility for producing and dispensing cannabidiol and

THC-A oils.1 Code § 54.1-3442.6(B) limits the Board to issuing one permit for each of the five

Health Services Areas (“HSAs”) in Virginia. The parties applied for the single permit available in

1 Cannabidiol and tetrahydrocannabinol acid (THC-A) are non-intoxicating Cannabis plant extracts, and the oils are statutorily defined according to their concentrations. See Code § 54.1-3408.3. HSA III located in southwest Virginia. The Board denied New Age’s application and granted

conditional approval for the permit to Dharma.

New Age appealed to Henrico County Circuit Court. Dharma moved to dismiss the appeal,

and the circuit court granted Dharma’s motion. New Age appeals the dismissal and argues the

circuit court erred by (1) “considering Dharma’s unilateral motion to dismiss;” (2) “granting

Dharma’s motion to dismiss on invalid grounds;” and (3) “prematurely ruling on the merits of New

Age’s appeal.” For the following reasons, we affirm the circuit court’s decision.

BACKGROUND

“Where, as here, ‘no evidence [has been] taken with regard to [a] motion to dismiss[,]

[appellate courts] treat the factual allegations in the petition as we do on review of a demurrer.’”

Bragg v. Bd. of Supervisors, 295 Va. 416, 423 (2018) (quoting Va. Marine Res. Comm’n v. Clark,

281 Va. 679, 686 (2011), overruled in part on other grounds by Woolford v. Va. Dep’t of Taxation,

294 Va. 377, 390 n.4 (2017)). “We accept ‘the truth of all material facts that are . . . expressly

alleged, impliedly alleged, and those that may be fairly and justly inferred from the facts alleged.’”

Id. (quoting Harris v. Kreutzer, 271 Va. 188, 195-96 (2006)). This “inquiry encompasses ‘not only

the substantive allegations of the pleading attacked but also any accompanying exhibit mentioned in

the pleading.’” Id. (quoting Flippo v. F & L Land Co., 241 Va. 15, 17 (1991)). See Rule 1:4(i).

Additionally, “[a] court in ruling upon a demurrer [or motion to dismiss] may consider

documents not mentioned in the challenged pleading when the parties so stipulate.” Flippo, 241 Va.

at 17. See Elder v. Holland, 208 Va. 15, 18 (1967) (considering on demurrer the transcript of a prior

hearing where parties so stipulate). This Court then “review[s] the circuit court’s decision to

dismiss the petition, and any corresponding issues of statutory interpretation, de novo.” Bragg, 295

Va. at 423. See also Graves v. Commonwealth, 294 Va. 196, 199 (2017); Harris, 271 Va. at

195-96. Here, employing these principles, we summarize New Age’s petition for appeal to the

-2- circuit court, its attached exhibit, and a stipulated subset of exhibits the parties submitted for

consideration along with Dharma’s motion to dismiss.

In 2018, the General Assembly amended 2016 legislation authorizing the Board to issue

pharmaceutical processor permits to operate cannabidiol/THC-A oil production and dispensary

facilities in each of the five HSAs in Virginia. See 2018 Va. Acts ch. 567. The amended statute

only allowed one permit for each HSA. Code § 54.1-3442.6(B). The final legislation also

authorized the Board to adopt regulations establishing health, safety, and security requirements for

the pharmaceutical processors. Code § 54.1-3442.6(C).

Pursuant to this statutory authority, the Board enacted regulations establishing a three-stage

application process: “submission of initial application, awarding of conditional approval, and

granting of a pharmaceutical processor permit.” 18 VAC 110-60-110(A).2 The regulations

identified the information required from each applicant, including the location where the

pharmaceutical processor would be operated; detailed information regarding the applicant’s

financial position; the applicant’s plans for security to prevent diversion, theft, or loss of the

Cannabis plants and the cannabidiol or THC-A oils; previous or current involvement in the medical

cannabidiol oil or THC-A oil industry; business and marketing plans; detailed blueprints; any

compassionate need program the applicant intended to offer; and the applicant’s expertise in

agriculture and other production techniques. 18 VAC 110-60-110(B)(b)-(d), (g), (i), (k)-(m).

The regulations also provided criteria for the Board to consider in evaluating the

applications, including compliance with the application requirements. 18 VAC 110-60-120(A), (B).

The regulations stated that “[t]he decision of the [B]oard not to grant conditional approval to an

applicant shall be final.” 18 VAC 110-60-120(C).

2 The regulations relevant to this appeal were effective from August 7, 2017, through February 6, 2019, but they have since been amended. -3- On April 16, 2018, the Board issued a request for applications (“RFA”) for pharmaceutical

processor permits in the five HSAs.3 The RFA, which was not a regulation, stated that “[t]he

review and scoring of the applications will be performed by an ad hoc committee appointed by the

Board.” The RFA stated that the ad hoc committee would score the applications and make a

recommendation to the Board: “After completing the review and scoring, the ad hoc committee will

rank each application according to its score. The committee will recommend to the Board the

issuance of conditional approval to an [a]pplicant in each [HSA] with the highest ranked score.”

The RFA specified that the ad hoc committee would score applications in the following

areas: the applicant’s financial position; location within the HSA; security plans; authorization to

conduct business; industry involvement and disciplinary action; agriculture, production, and

dispensing expertise; marketing plans; facility exterior and blueprints; product and site safety;

expected hours of operation; and an additional category consisting of plans for compassionate

needs, research, and delivery services to mitigate risks of diversion, theft, or loss.

The RFA also specifically stated that although the ad hoc committee would make a

recommendation to the Board based on its scoring of the applicants, the Board, not the ad hoc

committee, would make the final decision: “The Board will grant conditional approval to the

[a]pplicants which, in its opinion, have made the best application.”

The ad hoc committee, composed of two Board members and three citizen members, met in

Free access — add to your briefcase to read the full text and ask questions with AI

Related

James v. City of Falls Church
694 S.E.2d 568 (Supreme Court of Virginia, 2010)
Va Dept. of Health v. Nrv Real Estate, LLC
677 S.E.2d 276 (Supreme Court of Virginia, 2009)
Philip Morris USA v. CHESAOEAJE BAY
643 S.E.2d 219 (Supreme Court of Virginia, 2007)
Harris v. Kreutzer
624 S.E.2d 24 (Supreme Court of Virginia, 2006)
School Bd. of City of Norfolk v. Wescott
492 S.E.2d 146 (Supreme Court of Virginia, 1997)
Reston Hospital Center, LLC v. Remley
717 S.E.2d 417 (Court of Appeals of Virginia, 2011)
Boone v. Harrison
660 S.E.2d 704 (Court of Appeals of Virginia, 2008)
Citland, Ltd. v. Commonwealth Ex Rel. Kilgore
610 S.E.2d 321 (Court of Appeals of Virginia, 2005)
Finnerty v. Thornton Hall, Inc.
593 S.E.2d 568 (Court of Appeals of Virginia, 2004)
Flippo v. F & L LAND CO.
400 S.E.2d 156 (Supreme Court of Virginia, 1991)
Dudley v. Estate Life Insurance Co. of America
257 S.E.2d 871 (Supreme Court of Virginia, 1979)
Johnson v. Prince William County School Board
404 S.E.2d 209 (Supreme Court of Virginia, 1991)
Pence Holdings, Inc. v. Auto Center, Inc.
454 S.E.2d 732 (Court of Appeals of Virginia, 1995)
Vasaio v. Department of Motor Vehicles
590 S.E.2d 596 (Court of Appeals of Virginia, 2004)
Elder v. Holland
155 S.E.2d 369 (Supreme Court of Virginia, 1967)
Susan L. FRENCH VIRGINIA MARINE RESOURCES COMMISSION
767 S.E.2d 245 (Court of Appeals of Virginia, 2015)
Virginia Board of Medicine v. John Henry Hagmann, M.D.
797 S.E.2d 422 (Court of Appeals of Virginia, 2017)

Cite This Page — Counsel Stack

Bluebook (online)
New Age Care, LLC v. Caroline Juran, Executive Director, Counsel Stack Legal Research, https://law.counselstack.com/opinion/new-age-care-llc-v-caroline-juran-executive-director-vactapp-2020.